WO1992013967A1 - Device and method for the automated cycling of solutions between two or more temperatures - Google Patents

Device and method for the automated cycling of solutions between two or more temperatures Download PDF

Info

Publication number
WO1992013967A1
WO1992013967A1 PCT/AU1992/000021 AU9200021W WO9213967A1 WO 1992013967 A1 WO1992013967 A1 WO 1992013967A1 AU 9200021 W AU9200021 W AU 9200021W WO 9213967 A1 WO9213967 A1 WO 9213967A1
Authority
WO
WIPO (PCT)
Prior art keywords
carrier fluid
reaction mixture
dna
stream
contact
Prior art date
Application number
PCT/AU1992/000021
Other languages
French (fr)
Inventor
John Michael Corbett
Kenneth Clifford Reed
Arthur Dale Riggs
Original Assignee
The Beckman Research Institute Of The City Of Hope
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Beckman Research Institute Of The City Of Hope filed Critical The Beckman Research Institute Of The City Of Hope
Priority to AU11850/92A priority Critical patent/AU660652B2/en
Publication of WO1992013967A1 publication Critical patent/WO1992013967A1/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L7/00—Heating or cooling apparatus; Heat insulating devices
    • B01L7/52—Heating or cooling apparatus; Heat insulating devices with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/0046—Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L7/00—Heating or cooling apparatus; Heat insulating devices
    • B01L7/52—Heating or cooling apparatus; Heat insulating devices with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples
    • B01L7/525—Heating or cooling apparatus; Heat insulating devices with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples with physical movement of samples between temperature zones
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00277—Apparatus
    • B01J2219/00495—Means for heating or cooling the reaction vessels
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00583—Features relative to the processes being carried out
    • B01J2219/0059—Sequential processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718—Type of compounds synthesised
    • B01J2219/0072—Organic compounds
    • B01J2219/00722—Nucleotides
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B60/00—Apparatus specially adapted for use in combinatorial chemistry or with libraries
    • C40B60/14—Apparatus specially adapted for use in combinatorial chemistry or with libraries for creating libraries

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Clinical Laboratory Science (AREA)
  • Organic Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)

Abstract

The present invention provides an apparatus and method for the amplification of a particular sequence(s) of DNA in a sample using polymerase chain reaction. The method of the present invention involves the injection of a reaction mixture into a stream of carrier fluid. The carrier fluid then passes through a plurality of temperature zones in which the polymerase chain reactions take place. The method of the present invention allows the sequential processing of a number of samples.

Description

Device and Method for the Automated Cycling of Solutions Between Two or More Temperatures. Field of the Invention
The present invention relates to an apparatus and method for the automated cycling situation between two or more temperatures, with application, for example, in the amplification of nucleic acid sequences by heat-stable enzymes using thermal cycling. Background of the Invention In a number of applications such as gene analysis and DNA profiling, it is desirable to multiply the amount of particular nucleic acid sequences present in a sample. For example, a duplex DNA segment of up to 5,000 base pairs in length may be amplified many million-fold by means of the polymerase chain reaction (PCR;[1]), starting from as little as a single copy [2,3].
In this technique a denatured duplex DNA sample is incubated with a molar excess of two oligonucleotide primers, one being complementary to a short sequence in one strand of the DNA duplex and the other being identical to a second short sequence upstream of it (i.e. more 5 ' ) , such that each primer anneals to its complementary sequence and primes the template-dependent synthesis by a DNA polymerase of a complementary strand which extends beyond the site of annealing of the other primer, through the incorporation of deoxynucleotide triphosphates provided. Multiple cycles of denaturation, annealing and synthesis each afford an approximate doubling of the amount of target sequence, where the target sequence is defined as the DNA sequence subtended by and including the primers. Each cycle is controlled by varying the temperature to permit successive denaturation of complementary strands of duplex DNA, annealing of the primers to their complementary sequences and primed synthesis of new complementary DNA strands. The use of a thermostable DNA polymerase obviates the necessity of adding new enzyme for each cycle [4,5], thus allowing automation of the DNA amplification process simply by thermal cycling. Twenty amplification cycles increase the amount of target sequence by approximately one million-fold (being theoretically 2 20 but usually less in practice) .
The oligonucleotide primers used to prime DNA synthesis in the polymerase chain reaction need not necessarily complement sequences within the DNA of the sample but may be complementary to oligonucleotides that have been ligated to the termini of DNA fragments generated from the sample DNA by digestion with a restriction endonuclease or other means [6]. The polymerase chain reaction can be implemented with thermostable DNA polymerases isolated from a number of different sources and with enzymatically-active fragments and derivatives of naturally occurring thermostable DNA polymerases. In its most usual application the polymerase chain reaction is used to amplify DNA target sequences but it can be used also to provide amplified DNA sequences corresponding to RNA target sequences by first synthesizing DNA sequences complementary to the target RNA sequences. This is achieved by primed synthesis with a class of DNA polymerase enzyme known as reverse transcriptase. Reverse transcriptases are also capable of synthesizing DNA complementary to DNA templates and so may be used for primed DNA synthesis in the polymerase chain reaction. In particular a thermostable reverse transcriptase may be used for this purpose.
For the purposes of DNA analysis the polymerase chain reaction technique offers the advantage of providing a large amount of a specific sequence of DNA, whose extremities are defined by the included primers, sufficient for detailed analysis. More detailed information regarding the polymerase chain reaction technique can be found in Innis et al 1990 [7].
A further thermal cycling technique that is used to amplify specific target nucleic acid sequences is the ligation amplification reaction (LAR) . For exponential amplification with this technique, two pairs of oligonucleotides that are complementary to overlapping continuous portions of the complementary strands of a target sequence in sample DNA are ligated together in a template-dependent reaction catalysed by a DNA ligase enzyme. The duplex strands of DNA are then denatured by heating and the specific oligonucleotides again are allowed to anneal and are again ligated. Multiple cycles of denaturation, annealing and ligation each afford an approximate doubling of the amount of target sequence [8]. This procedure has particular application in discriminating between alleles that may differ by as little as a single base in their respective DNA sequences and is particularly useful in analysing the sequence of DNA products resulting from amplification of target sequences by the polymerase chain reaction [8] . The use of a thermostable DNA ligase in the ligation amplification reaction allows the procedure to be automated by thermal cycling. Devices for use in the automated thermal cycling of reaction mixtures for amplification of nucleic acid sequences typically consist of a heat conductive material provided with vertical cylindrical channels to receive vessels in which the reaction is to take place. The vessels typically are small plastic tubes with a conical lower section and an attached lid, typically capable of holding 0.5 ml or 1.5 ml of liquid and known as "Eppendorf tubes" . The heat conductive material is provided with heating/cooling means. One of the difficulties encountered in the use of such devices has been the achievement of rapid cooling of the reaction mixture. The most common solutions to this problem have been to use circulation of cold water, a standard refrigeration device, or a Peltier effect heat pump. The last named is the most desirable option but it suffers from the drawback that continual cycling between heating and cooling typically leads to failure of the Peltier effect heat pump.
Many present applications of nucleic acid amplification procedures in general and of the polymerase chain reaction in particular (and the anticipated area of most intensive application) is its use in routine, repetitive analysis of a particular sequence of genomic DNA that may be a gene or may be linked closely to a gene having sequence variants of known deleterious or beneficial effect ("gene diagnosis"). Such repetitive analyses of a single target sequence and its variants are particularly suited to automation.
Nucleic acid amplification procedures are not restricted to qualitative identification of specific nucleic acid sequences but can also be used to quantify the amount of particular nucleic acid sequences present in a sample. In particular they are commonly used to quantify the amount of RNA sequences present in a sample [9,10]. The application of thermal cycling amplification procedures to accurate quantitative analysis of nucleic acid sequences requires that all samples be exposed to identical thermal cycles, a requirement that is not met with presently available means for thermal cycling of sample reaction mixtures. The most critical problem in applying nucleic acid amplification procedures, particularly in repetitive diagnostic assays in a clinical laboratory, is contamination of the reaction mixture by small amounts of DNA which contain sequences capable of being amplified under the conditions of assay. The products of previous amplification reactions present a particular problem by virtue of their abundance and the fact that they comprise specific target sequences. Automation of procedures minimise the opportunity for such contamination and allows the implementation of stringent quality control. Summary of the Invention
In the first aspect the present invention consists in a method of cyclically heating and cooling a reaction mixture comprising:- i) injecting the reaction mixture into a stream of carrier fluid in which the reaction mixture is immiscible; ii) bringing the stream of carrier fluid containing the reaction mixture into contact with a plurality of different temperature zones, each temperature zone being held at a predetermined temperature and the stream of carrier fluid being in contact with each temperature zone for a pre-determined period of time; iii) repeating step 2 until the desired number of heating and cooling cycles has been achieved; and iv) recovering the reaction mixture from the carrier fluid
In the second aspect the present invention consists in an apparatus for use in cyclically heating and cooling a reaction mixture, the apparatus comprising a tube adapted to carry a stream of carrier fluid, the tube being provided with an inlet port to enable injection of the reaction mixture; pump means adapted to maintain the flow of the stream of carrier fluid through the tube; a plurality of zones at differing temperatures into contact with which the tube containing the fluid stream is brought for a predetermined period of time; and recovery means adapted to allow the removal of the reaction mixture from the carrier fluid following the desired number of heating and cooling cycle being achieved. In a third aspect the present invention consists in a method of amplifying the amount of a nucleic acid sequence present in a sample using the polymerase chain reaction. The sequence to be amplified may be a DNA sequence contained within the sample as a normal part of the DNA of the sample or it may be a fragment derived from the DNA of the sample to which oligonucleotide(s) have been ligated or it may be duplex DNA that has been synthesized such that one stand is complementary to and one strand is identical with an RNA sequence and to which oligonucleotide(s) may or may not have been ligated. The method comprises the following steps:-
(i) Adding thermostable DNA polymerase (or an enzymatically active fragment thereof or an enzymatically active derivative thereof or a reverse transcriptase) , suitable oligonucleotide primers, the four deoxyribonucleotide triphosphates and other desirable components to the sample to form a reaction mixture; (ϋ) Injecting the reaction mixture into a stream of carrier fluid, the reaction mixture being immiscible in the carrier fluid; (iii) Bringing the stream of the carrier fluid containing the reaction mixture into contact with a plurality of different temperature zones, the temperature of the different temperature zones and the time the carrier fluid containing the reaction mixture is in contact with the individual temperature zones being selected such that the following reactions take place in the reaction mixture: (a) denaturation of the DNA strands in the sample, (b) annealing of the oligonucleotide primers with complementary sequences in the sample DNA, and (c) primed synthesis of new strands of complementary DNA that each extend beyond the site of annealing of the alternate primer; (iv) Repeating step (iii) until the desired level of amplification has been achieved; and (v) Recovering the reaction mixture from the carrier fluid. In a fourth aspect the present invention consists in a device for use in amplifying the amount of specific target DNA sequence(s) present in a sample using the polymerase chain reaction, the device comprising a tube adapted to carry a stream of carrier fluid, the tube being provided with an inlet port to enable injection of a reaction mixture comprising the sample, thermostable DNA polymerase (or an enzymatically active fragment thereof or an enzymatically active derivative thereof or a reverse transcriptase), suitable oligonucleotide primers, the four deoxyribonucleotide triphosphates and other desirable components into the carrier fluid; pump means adapted to maintain the flow of the carrier fluid through the tube; a plurality of zones at differing temperatures into contact with which the tube containing the stream of carrier fluid is brought, the differing temperatures and the time for which the carrier fluid stream containing the reaction mixture is in contact with the individual zones being selected such that the following reactions take place in the reaction mixture: (a) denaturation of the DNA strands in the sample, (b) annealing of the oligonucleotide primers with complementary sequences in the sample DNA, and (c) primed synthesis of new strands of complementary DNA that each extend beyond the site of annealing of the alternate primer; and recovery means adapted to allow removal of the reaction mixture from the carrier fluid following amplification of the specific target DNA sequence(s) present in the sample.
In a preferred embodiment of the present invention there is provided an in-line analysis means downstream of the plurality of zones at differing temperatures. The in-line analysis means determines the extent of amplification which has occurred in the reaction mixture and may additionally determine the specificity of amplification of defined target DNA sequence(s).
In a preferred embodiment of the present invention there are two or three, and most preferably two, zones of differing temperature. Where there are three zones of differing temperature it is preferred that one zone is at about 94 C, one zone at about 60 C and one zone at about 73°C. It is preferred that the time taken for the fluid carrier" stream containing the reaction mixture to pass through these three zones is about 20 seconds, about 10 seconds and about 2 minutes, respectively. However, the most suitable temperatures of the three differing zones and the most suitable time taken for the fluid carrier stream containing the reaction mixture to pass through these three zones is dependent on the enzyme used for DNA synthesis, the sequence composition of the oligonucleotide primers and the sequence composition of the defined target DNA sequence(s) in the sample. Where there are two zones of differing temperature it is preferred that these zones are at about 94°C and at about 70 C and that the time taken for the fluid carrier stream containing the reaction mixture to pass through these two zones is about 30 seconds and about 2 minutes, respectively. However, the most suitable temperatures for the two differing zones and the most suitable time taken for the fluid carrier stream containing the reaction mixture to pass through these two zones is dependent on the enzyme used for DNA synthesis, the sequence composition of the oligonucleotide primers and the sequence composition of the defined target DNA sequence(s) in the sample.
In a fifth aspect the present invention consists in a method of amplifying the amount of a nucleic acid sequence present in a sample using the ligation amplification reaction. The sequence to be amplified may be a DNA sequence contained within the sample as a normal part of the DNA of the sample or it may be duplex DNA that has been synthesized such that one stand is complementary to and one strand is identical with an RNA sequence. The method comprises the following steps:-
(i) Adding thermostable DNA ligase (or an enzymatically active fragment thereof or an enzymatically active derivative thereof), suitable oligonucleotides, ATP or similar required nucleotide and other desirable components to the sample to form a reaction mixture; (ii) Injecting the reaction mixture into a stream of carrier fluid, the reaction mixture being immiscible in the carrier fluid; (iii) Bringing the stream of the carrier fluid containing the reaction mixture into contact with a plurality of different temperature zones, the temperature of the different temperature zones and the time the carrier fluid containing the reaction mixture is in contact with the individual temperature zones being selected such that the following reactions take place sequentially in the reaction mixture: (a) denaturation of the DNA strands in the sample, (b) annealing of the oligonucleotides with complementary sequences in the sample DNA, and (c) ligation of adjacent annealed oligonucleotides; (iv) Repeating step (iii) until the desired level of amplification has been achieved; and (v) Recovering the reaction mixture from the carrier fluid. In a sixth aspect the present invention consists in a device for use in amplifying the amount of specific target DNA sequence(s) present in a sample using the ligation amplification reaction, the device comprising a tube adapted to carry a stream of carrier fluid, the tube being provided with an inlet port to enable injection of a reaction mixture comprising the sample, thermostable DNA ligase (or an enzymatically active fragment thereof or an enzymatically active derivative thereof) , suitable oligonucleotides, ATP or similar required nucleotide and other desirable components into the carrier fluid; pump means adapted to maintain the flow of the carrier fluid through the tube; a plurality of zones at differing temperatures into contact with which the tube containing the stream of carrier fluid is brought, the differing temperatures and the time for which the carrier fluid stream containing the reaction mixture is in contact with the individual zones being selected such that the following reactions take place in the reaction mixture: (a) denaturation of the DNA strands in the sample, (b) annealing of the oligonucleotides with complementary sequences in the sample DNA, and (c) ligation of adjacent annealed oligonucleotides; and recovery means adapted to allow removal of the reaction mixture from the carrier fluid following amplification of the specific target DNA sequence(s) present in the sample.
In a preferred embodiment of the present invention there is provided an in-line analysis means downstream of the plurality of zones at differing temperatures. The in-line analysis means determines the extent of amplification which has occurred in the reaction mixture and may additionally determine the specificity of amplification of defined target DNA sequence(s).
The number of differing temperature zones, the most suitable temperatures for the differing zones and the most suitable time taken for the fluid carrier stream containing the reaction mixture to pass through these zones is dependent on the enzyme used for DNA ligation and the sequence composition of the oligonucleotides.
Whilst the cycling of a reaction mixture from one temperature zone to another may be achieved by arranging a number of individual temperature zones along the fluid stream path, it is presently preferred that there are simply two or three individual temperature zones and the stream of carrier fluid, by following a convoluted path, flows through or into contact with the individual temperature zones a plurality of times. In the situation where there are two individual temperature zones the fluid path goes from the first temperature zone to the second temperature zone from where it flows back to the first temperature zone and so on.
In a particularly preferred arrangement the individual temperature zones are cylinders with the tube carrying the carrier fluid being wrapped around individual cylinders within enclosed vessels. For example, the tube may be wrapped around a cylinder at 94°C once from where it passes to a cylinder of similar diameter at 70°C around which it is wrapped four times. By simply varying the diameter of the cylinders and the number of times the tube passes around a particular cylinder the time that the reaction mixture is in contact with the cylinder can be varied. The cylinders around which the tube is wrapped may be provided with thermostatically controlled heating/cooling means or the cylinders with the tube wrapped around them may be immersed in an enclosed vessel of fluid that is provided with thermostatically controlled heating/cooling means.
Due to the fact that the reaction mixture is immiscible in the carrier fluid, the reaction mixture passes along with the fluid stream as a discrete pocket or plug. As will be readily envisaged, this enables the method and apparatus of the present invention to be used in sequential processing of multiple samples. This is achieved by simply spacing the reaction mixtures along the stream of carrier fluid by spacing the injection of different reaction mixtures in time.
Whilst the separation of the different reaction mixtures by carrier fluid is generally sufficient to ensure against mixing of the separate reaction mixtures, it is presently preferred that a pocket or plug of purging solution destructive to DNA such as sodium hypochlorite or hydrochloric acid is provided in the carrier stream between the individual reaction mixtures. As will be envisaged, any carry-over of DNA from one reaction mixture to the next will be substantially prevented from adversely affecting the procedure in the second reaction mixture by its destruction by the purging solution. It is also preferred that this purging solution is introduced into the fluid stream through the same inlet port through which the reaction mixtures are introduced into the fluid stream. This serves to prevent any carry-over of one reaction mixture to another which may occur by virtue of contamination of the inlet port with DNA components of a previous reaction mixture.
As stated above, individual reaction mixtures are separated by a volume of carrier fluid. In order to prevent mixing of one reaction mixture with a subsequent reaction mixture it is preferable that back pressure is exerted on the fluid stream to prevent vaporisation of the fluid stream and reaction mixtures as they pass through the zone(s) of high temperature. This is preferably achieved by the provision of back pressure means at the end of the fluid stream.
In addition, to aid in preventing mixing of reaction mixtures it is preferred that the flow rate and cross-sectional diameter of the fluid stream are such that turbulent flow is avoided and laminar flow is achieved. Tubing of small diameter is particularly preferred since it is beneficial to rapid heat transfer.
The carrier fluid may be any of a number of fluids in which the reaction mixture is immiscible. However, it is presently preferred that the carrier fluid is either a silicone oil or mineral oil.
In yet a further preferred embodiment the fluid stream containing the reaction mixture is brought into contact with a cooling zone after the desired number of cycles has been completed. DETAILED DESCRIPTION OF THE INVENTION
In order that the nature of the present invention may be more clearly understood, a preferred form thereof as used for the polymerase chain reaction will now be described with reference to the accompanying drawings in which:-
Figure 1 is a schematic representation of a preferred embodiment of the apparatus of the present invention; and Figure 2 is an expanded view of tube 12 of Figure 1. As is shown in figure 1, the apparatus 10 comprises tube 12 through which a fluid stream passes. As is more clearly shown in Figure 2, the fluid stream includes pockets of reaction mixtures 42 and 44 and purging solution 48 separated by carrier fluid 46.
Provided at one end of tube 12 is pump means 14. The pump means maintains the flow of liquid along tube 12 in the direction shown by arrows 15. Provided on tube 12 is inlet port 16 through which reaction mixture is injected by means 24 and purging solution is injected by means 26. The apparatus 10 includes temperature zones 18, 20 and 22. The temperature of zone 18 is approximately 94°C, the temperature of zone 20 is approximately 60 C and the temperature of zone 22 is approximately 73 C. Tube 12 is arranged between temperature zones 18, 20 and 22 such that the tube passes back and forth between the zones a plurality of times and has a different length in each zone depending on the residence of flowing fluid required. Downstream of temperature zones 18, 20 and 22 is temperature zone 34 which is typically at ambient temperature but may be at 4 C or thereabouts.
Downstream of temperature zone 34 is in-line analysis means 29 and recovery means 28. Connected to recovery means 28 is detection means 30. Detection means 30 determines when a reaction mixture in the carrier fluid reaches recovery means 28. This may be done by measuring the conductivity or optical density of the stream of carrier fluid. As the conductivity and optical density of the reaction mixtures differ from those of the carrier fluid the arrival of a reaction mixture at the recovery means 28 may be readily detected. Upon detection of a reaction mixture recovery means 28 is actuated and the reaction mixture is recovered from the fluid stream.
At the end of tube 12 remote from pump means 14 is provided back pressure device 32. This enables a positive pressure to be maintained throughout tube 12 which prevents bubble formation due to vaporisation in the fluid stream in any of temperature zones 18, 20 or 22.
In operation, pump means is actuated and carrier fluid is pumped through tube 12 which is arranged between temperature zones 18, 20 and 22 such that tube 12 passes back and forth between zones 18, 20 and 22 up to forty times and may have a different length in each of zones 18, 20 and 22 depending on the residence time of flowing fluid required. A reaction mixture comprising the sample containing the DNA sequence(s) to be amplified, thermostable DNA polymerase (or an enzymatically active fragment thereof or an anzymatically active derivative thereof or a reverse transcriptase), suitable oligonucleotide primers, the four deoxyribonucleotide triphospohates and other desirable components in a small volume, approximately 5-20 ul, is injected by means 24 into tube 12 via inlet port 16. The carrier fluid 46 carries the reaction mixture 44 through temperature zone 18, in which DNA strands are denatured, to temperature zone 20, where annealing of the oligonucleotide primers takes place, to temperature zone 22, where synthesis of new DNA stands takes place, then back to temperature zone 18. A small volume of purging solution 48 is injected after reaction mixture 44 by means 26 into tube 12 via inlet port 16. The next reaction mixture 42 is then injected by means 24 into tube 12 via inlet port 16. These processes can be repeated continuously at intervals of a few seconds, depending on the flow rate along tube 12.
After multiple passes through zones 18, 20 and 22 the amplified reaction mixtures 44 and 42 are cooled by means 34 and then reach in-line analysis means 29 where the degree of amplification is assessed and the specificity of amplification may be assessed. From in-line analysis means 29 reaction mixtures 44 and 42 pass to recovery means 28 where their presence is detected by detection means 30. This actuates the recovery means 28 and the amplified samples are recovered from the fluid stream in tube 12. Positioned downstream of recovery means 28 is back pressure means 32. The back pressure means 32 maintains system pressure at approximately 60 - 100 PSIG to prevent bubble formation in the reaction mixture or carrier fluid. In order that the nature of the present invention may be more clearly understood, a preferred form thereof utilising the polymerase chain reaction will now be described with reference to the following proposed example. EXAMPLE
The sample containing the DNA sequences to be amplified is mixed with thermostable DNA polymerase, suitable oligonucleotide primers, dATP, dCTP, dGTP and dTTP and other desirable components in a volume of 25μl or less, depending on the volume to be injected.
Two heated zones are set up, one at 94 C and one at 70°C. A pump which delivers a flow rate of lOOμl per minute is connected to a tube composed of material inert to both the- reaction mixture and carrier fluid. The tube is arranged so that the residence time of flowing fluid is five minutes at 94°C. The tube then passes to the 70 C zone such that the residence time of flowing fluid is two minutes and then passes back to the 94 C zone such that the residence time of flowing fluid is 30 seconds. The tube passes back and forth in this arrangement (two minutes fluid residence at 70 then 30 second fluid residence at 94°C) twenty to forty times, depending on the extent of amplification required. After leaving the 70 C zone for the final time the tube then passes through a cooling zone and then via the sample collection valve to the back pressure device.
The pump is actuated and the reaction mixture of 20μl or less is injected into the mineral oil or silicone oil carrier fluid and specific DNA sequences (whose limits are defined by the oligonucleotide primers) present in the sample are amplified as it passes cyclically through the temperature zones.
A few seconds after a reaction mixture is injected a small amount (5μl) of purging reagent, e.g. sodium hypochlorite or hydrochloric acid, is injected into the tube. This is separated from the reaction mixture by carrier fluid that has flowed by in the time between successive injection of the reaction mixture and the purging reagent. After a similar delay another reaction mixture is injected and the process repeated. In this manner many samples .may be amplified without possibility of carry-over from one sample to another. In particular, amplified products of one sample are not at any stage in contact with or proximate to unamplified components of another sample. Successive samples can be applied at intervals of 30 seconds or less and after the total reaction time emerge amplified and be recovered at intervals of 30 seconds or less.
The apparatus and method of the present invention provides a rapid and automated means by which DNA sequences in a large number of samples can be amplified in continuous sequence by thermostable enzymes using thermal cycling. As stated previously, one of the main drawbacks encountered in prior art devices for the amplification of nucleic acid sequences by means of thermal cycling is achieving rapid and uniform heating and cooling of the reaction mixtures. In the present invention the high ratio of surface area to volume of the fluid stream enables a rapid transfer of heat to and from the reaction mixtures, all of which are subjected to identical thermal environments. The last consideration is of particular value in the application of nucleic acid amplification procedures to the quantification of defined nucleic acid sequences. The apparatus and method of the present invention provides the further advantages that the application of samples can be automated with an automated sample injection device, thereby minimising both the number of manual procedures required and the opportunity for inadvertent contamination while increasing the opportunity for quality control. The further possibility exists for inclusion of an automated means for in-line analysis of the amplified reaction product(s) .
The automated injection of samples may be further accomplished by injection of DNA sample into a plug of reaction mixture containing thermostable DNA polymerase, suitable oligonucleotide primers, the four deoxyribonucleotide triphosphates and other desirable components. The individual temperature zones may be formed of any material of relatively high thermal conductivity. Alternatively, the individual temperature zones may be fluid-filled baths maintained thermostatically at the required temperature. It will be appreciated by persons skilled in the art that numerous variations and/or modifications may be made to the invention as shown in the specific embodiments without departing from the spirit or scope of the invention as broadly described. The present embodiments are, therefore, to be considered in all respects as illustrative and not restrictive. References
1. Saiki, R.K. , Scharf, S., Faloona, F., Mullis, K.B., Horn, G.T., Erlich, H.A. and Arnheim, N. (1985) Enzymatic amplification of 3-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia, Science 230, 1350-1354.
2. Li, H., Gyllensten, U.B., Cui, X., Saiki, R.K., Erlich, H.A. and Arnheim, N. (1988) Amplification and analysis of DNA sequences in single human sperm and diploid cells, Nature 335, 414-417.
3. Holding, C. and Monk, M. (1989) Diagnosis of beta-thalassaemia by DNA amplification in single blastomeres from mouse preimplantation embryos, Lancet i±, 532-535. 4. Australian Patent Application No. 77298/87.
5. Saiki, R.K., Gelfand, D.H., Stoffel, S., Scharf, S.J., Higuchi, R., Horn, G.T., Mullis, K.B. and Erlich, H.A. (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase, Science 239. 487-491.
6. Steigerwald, S.D., Pfeifer, G.P. and Riggs, A.D. (1990) Ligation-mediated PCR improves the sensitivity of methylation analysis by restriction enzymes and detection of specific DNA strand breaks, Nucl. Acids Res. 18, 1435-1439.
7. Innis, M.A., Gelfand, D.H., Sninsky J.J. and White, T.J., Eds. (1990) "PCR Protocols. A Guide to Methods and Applications". (Academic Press, Inc., San Diego CA) .
8. Wu, D.Y. and Wallace, R.B. (1989) The ligation amplification reaction (LAR) - Amplification of specific DNA sequences using sequential rounds of template-dependent ligation, Genomics 4., 560-569. 9. Singer-Sam, J., Robinson, M.O., Bellve, A.R., Simon, M.I. and Riggs, A.D. (1990) Measurement by quantitative PCR of changes in HPRT, PGK-1, PGK-2, APRT, MTase, and Zfy gene transcripts during mouse spermatogenesis, Nucl. Acids Res. .18., 1256-1259. 10. Chelly, J., Montarras, D., Pinset, C,
Berwald-Netter, Y. , Kaplan, J.-C. and Kahn, A. (1990) Quantitative estimation of minor mRNAs by cDNA-polymerase chain reaction. Application to dystrophin mRNA in cultured myogenic and brain cells, Eur. J. Biochem. 187, 691-698.

Claims

CLAIMS : -
1. A method of cyclically heating and cooling a reaction mixture comprising: i) injecting the reaction mixture into a stream of carrier fluid in which the reaction mixture is immiscible; ii) bringing the stream of carrier fluid containing the reaction mixture into contact with a plurality of different temperature zones, each temperature zone being held at a predetermined temperature and the stream of carrier fluid being in contact with each temperature zone for a pre-determined period of time; iii) repeating step 2 until the desired number of heating and cooling cycles has been achieved; and iv) recovering the reaction mixture from the carrier fluid.
2. A method as claimed in claim 1 in which a second reaction mixture is injected into the fluid stream upstream of the first reaction mixture, the two reaction mixtures being separated by carrier fluid.
3. A method as claimed in claim 2 in which a purging reagent destructive to DNA is injected into the stream of carrier fluid between the two reaction mixtures.
4. A method as claimed in claim 1 in which, prior to step (iv), the carrier fluid is brought into contact with a cooling zone.
5. An apparatus for use in cyclically heating and cooling a reaction mixture, the apparatus comprising a tube adapted to carry a stream of carrier fluid, the tube being provided with an inlet port to enable injection of the reaction mixture; pump means adapted to maintain the flow of the stream of carrier fluid through the tube; a plurality of zones at differing temperatures which into contact with which the tube containing the fluid stream is brought for a predetermined period of time; and recovery means adapted to allow the removal of the reaction mixture from the carrier fluid following the desired number of heating and cooling cycles being achieved.
6. An apparatus as claimed in claim 5 in which the tube passes around each of the temperature zones.
7. An apparatus as claimed in claim 5 in which the apparatus includes a cooling zone into contact with which the carrier fluid is brought prior to reaching the recovery means.
8. A method of amplifying the amount of DNA present in a sample using the polymerase chain reaction comprising the following steps:- i) Adding thermostable DNA polymerase or an enzymatically active fragment thereof or an enzymatically active derivative thereof or a reverse transcriptase and suitable oligonucleotide primers, the four deoxyribonucleotide triphosphates and other desirable components to the sample to form a reaction mixture; ii) Injecting the reaction mixture into a stream of carrier fluid in which the reaction mixture is immiscible; iii) Bringing the stream of carrier fluid containing the reaction mixture into contact with a plurality of different temperature zones, the temperature of the different temperature zones and the time the carrier fluid containing the reaction mixture is in contact with the individual temperature zones being selected such that the following reactions take place in the reaction mixture:-
(a) denaturation of the DNA strands in the sample, (b) annealing of the oligonucleotide primers with complementary sequences in the same DNA, and (c) primed synthesis of new strands of complementary DNA that each extend beyond the site of annealing of the alternate primer; iv) Repeating step 3 until the desired level of amplification has been achieved; and v) Recovering the reaction mixture from the carrier fluid.
9. A method as claimed in claim 8 in which prior to step (v) the extent and/or specificity of amplification is assessed by in-line analysis means.
10. A method as claimed in claim 8 in which there are three temperature zones and the carrier fluid cyclically passes through or into contact with the three temperature zones.
11. A method as claimed in claim 8 in which there are two temperature zones.
12. A method as claimed in claim 8 in which a second reaction mixture is injected into the fluid stream upstream of the first reaction mixture, the two reaction mixtures being separated by carrier fluid.
13. A method as claimed in claim 12 in which a purging reagent destructive to DNA is injected into the stream of carrier fluid between the two reaction mixtures.
14. A method a claimed in claim 8 in which, prior to step (v) , the carrier fluid is brought into contact with a cooling zone.
15. An apparatus for use in amplifying the amount of DNA or RNA present in a sample using the polymerase chain reaction, the apparatus comprising a tube adapted to carry a stream of carrier fluid, the tube being provided with an inlet port to enable injection of a reaction mixture comprising the sample, thermostable DNA polymerase (or an enzymatically active fragment thereof or an enzymatically active derivative thereof or a reverse transcriptase), suitable oligonucleotide primers, the four deoxyribonucleotide triphosphates and other desirable components into the carrier fluid; pump means adapted to maintain the flow of the stream of carrier fluid through the tube; a plurality of zones at differing temperatures into contact with which the tube containing the carrier fluid is brought, the differing temperatures and the time for which the carrier fluid containing the reaction mixture is in contact with the individual zones being selected such that the following reactions take place in the reaction mixture: (a) denaturation of the DNA strands in the sample, (b) annealing of the oligonucleotide primers with complementary sequences in the sample DNA, and (c) primed synthesis of new strands of target DNA sequence whose limits are defined by the primers; and recovery means adapted to allow removal of the reaction mixture from the carrier fluid following amplification of the specific target DNA sequence(s) present in the sample.
16. An apparatus as claimed in claim 15 in which an in-line analysis means adapted to assess the extent and/or specificity of amplification in the reaction is provided downstream of the plurality of zones at differing temperatures.
17. An apparatus as claimed in claim 15 in which there are three temperature zones and the carrier fluid cyclically passes through or into contact with the three temperature zones.
18. An apparatus as claimed in claim 15 in which there are two temperature zones.
19. An apparatus as claimed in claim 15 in which the tube passes around each of the temperature zones.
20. An apparatus as claimed in claim 15 in which the apparatus includes a cooling zone into contact with which the carrier fluid is brought prior to reaching the recovery means.
21. A method of amplifying the amount of DNA or RNA present in a sample using the ligation amplification reaction comprising the following steps:- (i) adding thermostable DNA ligase (or an enzymatically active fragment thereof or an enzymatically active derivative thereof), suitable oligonucleotides, ATP or similar required nucleotide and other desirable components to the sample to form a reaction mixture; (ii) injecting the reaction mixture into a stream of carrier fluid, the reaction mixture being immiscible in the carrier fluid;
(iii) bringing the stream of the carrier fluid containing the reaction mixture into contact with a plurality of different temperature zones, the temperature of the different temperature zones and the time the carrier fluid containing the reaction mixture is in contact with the individual temperature zones being selected such that the following reactions take place sequentially in the reaction mixture: (a) denaturation of the DNA strands in the mixture, (b) annealing o the oligonucleotides with complementary sequences in the DNA of the mixture, and (c) ligation of adjacent oligonucleotides; (iv) repeating step (iii) until the desired level of amplification has been achieved; and (v) recovering the reaction mixture from the carrier fluid.
22. A method as claimed in claim 21 in which prior to step (v) the extent and/or specificity of amplification is assessed by in-line analysis means.
23. A method as claimed in claim 21 in which there are three temperature zones and the carrier fluid cyclically passes through or into contact with the three temperature zones.
24. A method as claimed in claim 21 in which there are two temperature zones.
25. A method as claimed in claim 21 in which a second reaction mixture is injected into the fluid stream upstream of the first reaction mixture.
26. A method as claimed in claim 25 in which a purging reagent destructive to DNA is injected into the stream of carrier fluid between the two reaction mixtures, being separated from each by carrier fluid.
27. A method as claimed in claim 21 in which, prior to step (v) , the carrier fluid is brought into contact with a cooling zone.
28. An apparatus for use in amplifying the amount of DNA or RNA present in a sample using the ligation amplification reaction, the apparatus comprising a tube adapted to carry a stream of carrier fluid, the tube being provided with an inlet port to enable injection of a reaction mixture comprising the sample, thermostable DNA ligase or an enzymatically active fragment thereof or an enzymatically active derivative thereof, suitable oligonucleotides, ATP or similar required nucleotide and other desirable components into the carrier fluid; pump means adapted to maintain the flow of the stream of carrier fluid through the tube; a plurality of zones at differing temperatures into contact with which the tube containing the carrier fluid is brought, the differing temperatures and the time for which the carrier fluid containing the reaction mixture is in contact with the individual zones being selected such that the following reactions take place in the reaction mixtures: (a) denaturation of the DNA strands in the sample, (b) annealing of the oligonucleotides with complementary sequences in the sample DNA, and (c) ligation of adjacent oligonucleotides; and recovery means adapted to allow removal of the reaction mixture from the carrier fluid following amplification of the specific target DNA sequence(s) present in the sample.
29. An apparatus as claimed in claim 28 in which an in-line analysis means adapted to assess the extent and/or specificity of amplification in the reaction is provided downstream of the plurality of zones at differing temperatures.
30. An apparatus as claimed in claim 28 in which there are three temperature zones and the carrier fluid cyclically passes through or into contact with the three temperature zones.
31. An apparatus as claimed in claim 28 in which there are two temperature zones.
32. An apparatus as claimed in claim 28 in which the tube passes around each of the temperature zones.
33. An apparatus as claimed in claim 28 in which the apparatus includes a cooling zone into contact with which the carrier fluid is brought prior to reaching the recovery means.
PCT/AU1992/000021 1991-02-08 1992-01-21 Device and method for the automated cycling of solutions between two or more temperatures WO1992013967A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU11850/92A AU660652B2 (en) 1991-02-08 1992-01-21 Device and method for the automated cycling of solutions between two or more temperatures

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/653,659 US5270183A (en) 1991-02-08 1991-02-08 Device and method for the automated cycling of solutions between two or more temperatures
US653,659 1991-02-08

Publications (1)

Publication Number Publication Date
WO1992013967A1 true WO1992013967A1 (en) 1992-08-20

Family

ID=24621811

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/AU1992/000021 WO1992013967A1 (en) 1991-02-08 1992-01-21 Device and method for the automated cycling of solutions between two or more temperatures

Country Status (3)

Country Link
US (1) US5270183A (en)
AU (1) AU660652B2 (en)
WO (1) WO1992013967A1 (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994010564A1 (en) * 1992-11-05 1994-05-11 Evotec Biosystems Gmbh Process for separating substances from dilute solutions and suspensions
EP0636413A2 (en) * 1993-07-28 1995-02-01 The Perkin-Elmer Corporation Nucleic acid amplification reaction apparatus and method
WO1996010456A1 (en) * 1994-09-30 1996-04-11 Biometra Biomedizinische Analytik Gmbh Miniaturized flow thermocycler
GB2325464A (en) * 1997-04-23 1998-11-25 Bruker Franzen Analytik Gmbh Capillary polymerase chain reaction
WO1999041015A1 (en) * 1998-02-11 1999-08-19 Institut für Physikalische Hochtechnologie e.V. Miniaturized temperature-zone flow reactor
AT4070U3 (en) * 1999-11-12 2001-07-25 Rosinger Anlagentechnik Gmbh & FERMENTATION REACTOR WITH TIP SAFETY REGARDING BIOLOGY
GB2366793A (en) * 2000-09-13 2002-03-20 Imperial College Chemical processing system
DE10149684B4 (en) * 2001-10-09 2005-02-17 Clondiag Chip Technologies Gmbh Device for holding a substance library carrier
AU2001237585B2 (en) * 2000-03-08 2006-04-27 The Secretary Of State For Defence Reaction system for thermal cycling
EP1784505A1 (en) * 2004-09-02 2007-05-16 Bioneer Corporation Miniaturized apparatus for real-time monitoring
WO2008126827A1 (en) * 2007-04-06 2008-10-23 Universal Bio Research Co., Ltd. Temperature control device, and temperature control method
EP2354256A1 (en) * 2004-02-24 2011-08-10 Thermal Gradient Thermal cycling device
WO2017121238A1 (en) * 2016-01-15 2017-07-20 北京酷搏科技有限公司 Thermal cycle reaction component and real-time detection device having same
RU2750599C1 (en) * 2017-06-06 2021-06-29 Ниппон Шит Глас Кампани, Лимитед Apparatus for conducting a reaction

Families Citing this family (178)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5482862A (en) * 1991-04-04 1996-01-09 The Dow Chemical Company Methods for the on-line analysis of fluid streams
CA2065719A1 (en) * 1991-04-30 1992-10-31 John B. Findlay Nucleic acid amplification and detection methods using rapid polymerase chain reaction cycle
US7297313B1 (en) 1991-08-31 2007-11-20 The Regents Of The University Of California Microfabricated reactor, process for manufacturing the reactor, and method of amplification
US5498392A (en) * 1992-05-01 1996-03-12 Trustees Of The University Of Pennsylvania Mesoscale polynucleotide amplification device and method
US5587128A (en) * 1992-05-01 1996-12-24 The Trustees Of The University Of Pennsylvania Mesoscale polynucleotide amplification devices
US5726026A (en) * 1992-05-01 1998-03-10 Trustees Of The University Of Pennsylvania Mesoscale sample preparation device and systems for determination and processing of analytes
US6953676B1 (en) 1992-05-01 2005-10-11 Trustees Of The University Of Pennsylvania Mesoscale polynucleotide amplification device and method
US5612200A (en) * 1992-06-24 1997-03-18 Gen-Probe Incorporated Method and kit for destroying ability of nucleic acid to be amplified
US5639423A (en) * 1992-08-31 1997-06-17 The Regents Of The University Of Calfornia Microfabricated reactor
US6495676B1 (en) 1993-04-13 2002-12-17 Naxcor Nucleic acid sequence detection employing probes comprising non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents
US5767259A (en) 1994-12-27 1998-06-16 Naxcor Oligonucleotides containing base-free linking groups with photoactivatable side chains
US6277570B1 (en) 1993-04-13 2001-08-21 Naxcor Nucleic acid sequence detection employing probes comprising non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents
US5415839A (en) * 1993-10-21 1995-05-16 Abbott Laboratories Apparatus and method for amplifying and detecting target nucleic acids
DE4409436A1 (en) * 1994-03-19 1995-09-21 Boehringer Mannheim Gmbh Process for processing nucleic acids
US7235406B1 (en) 1996-04-03 2007-06-26 Applera Corporation Nucleic acid analysis device
US7244622B2 (en) * 1996-04-03 2007-07-17 Applera Corporation Device and method for multiple analyte detection
US6825047B1 (en) * 1996-04-03 2004-11-30 Applera Corporation Device and method for multiple analyte detection
JP4912517B2 (en) * 1996-04-03 2012-04-11 アプライド バイオシステムズ リミテッド ライアビリティー カンパニー Devices and methods for detection of multiple analytes
EP0927265A4 (en) * 1996-06-17 2000-07-12 Trustees Of Board Of Thermocycling apparatus and method
US5779868A (en) * 1996-06-28 1998-07-14 Caliper Technologies Corporation Electropipettor and compensation means for electrophoretic bias
WO1998000705A1 (en) * 1996-06-28 1998-01-08 Caliper Technologies Corporation Electropipettor and compensation means for electrophoretic bias
US5958349A (en) * 1997-02-28 1999-09-28 Cepheid Reaction vessel for heat-exchanging chemical processes
US6410275B1 (en) 1997-05-02 2002-06-25 Biomerieux, Inc. Disposable test devices for performing nucleic acid amplification reactions
US6429007B1 (en) * 1997-05-02 2002-08-06 BIOMéRIEUX, INC. Nucleic acid amplification reaction station for disposable test devices
US5965410A (en) 1997-09-02 1999-10-12 Caliper Technologies Corp. Electrical current for controlling fluid parameters in microchannels
US6174675B1 (en) 1997-11-25 2001-01-16 Caliper Technologies Corp. Electrical current for controlling fluid parameters in microchannels
US7799521B2 (en) * 1998-06-24 2010-09-21 Chen & Chen, Llc Thermal cycling
US6780617B2 (en) 2000-12-29 2004-08-24 Chen & Chen, Llc Sample processing device and method
US6322683B1 (en) 1999-04-14 2001-11-27 Caliper Technologies Corp. Alignment of multicomponent microfabricated structures
CA2379927A1 (en) * 1999-07-28 2001-02-01 Genset S.A. Integration of biochemical protocols in a continuous flow microfluidic device
FR2796863B1 (en) * 1999-07-28 2001-09-07 Commissariat Energie Atomique PROCESS AND DEVICE FOR CONDUCTING A HEAT TREATMENT PROTOCOL ON A SUBSTANCE IN CONTINUOUS FLOW
US6977145B2 (en) * 1999-07-28 2005-12-20 Serono Genetics Institute S.A. Method for carrying out a biochemical protocol in continuous flow in a microreactor
FR2799139B1 (en) * 1999-10-01 2002-05-03 Genset Sa BIOCHEMICAL ANALYSIS DEVICE COMPRISING A MICROFLUIDIC SUBSTRATE, PARTICULARLY FOR THE AMPLIFICATION OR ANALYSIS OF NUCLEIC ACIDS.
US20020003001A1 (en) * 2000-05-24 2002-01-10 Weigl Bernhard H. Surface tension valves for microfluidic applications
US7440684B2 (en) * 2001-04-12 2008-10-21 Spaid Michael A Method and apparatus for improved temperature control in microfluidic devices
US20030032172A1 (en) * 2001-07-06 2003-02-13 The Regents Of The University Of California Automated nucleic acid assay system
JP2003024063A (en) * 2001-07-12 2003-01-28 Toshio Kawai Method for continuously amplifying dna and device for the same
ATE522776T1 (en) * 2001-07-16 2011-09-15 Idaho Technology Inc TEMPERATURE CHANGING SYSTEM AND METHOD OF USE
AUPR707101A0 (en) * 2001-08-16 2001-09-06 Corbett Research Pty Ltd Continuous flow thermal device
JP4513085B2 (en) 2001-09-11 2010-07-28 アイキューム インク Sample container
KR100488281B1 (en) * 2001-09-15 2005-05-10 아람 바이오시스템 주식회사 Method and apparatus for amplification of nucleic acid sequences by using thermal convection
US20030062833A1 (en) * 2001-10-03 2003-04-03 Wen-Yen Tai Mini-type decorative bulb capable of emitting light through entire circumferential face
WO2003038127A1 (en) * 2001-10-30 2003-05-08 Ahram Biosystems Inc. Method and apparatus for amplification of nucleic acid sequences using immobilized dna polymerase
KR100442836B1 (en) * 2001-11-10 2004-08-02 삼성전자주식회사 System and method for circulating biochemical fluidic solutions around closed two or more temperature zones of chambers
US6859050B2 (en) 2002-05-31 2005-02-22 Agilent Technologies, Inc. High frequency contactless heating with temperature and/or conductivity monitoring
KR100740869B1 (en) 2002-09-13 2007-07-19 아람 바이오시스템 주식회사 Method and apparatus for amplification of nucleic acid sequences using immobilized dna polymerase
US20040136497A1 (en) * 2002-10-30 2004-07-15 Meldrum Deirdre R Preparation of samples and sample evaluation
WO2004080597A2 (en) 2003-02-05 2004-09-23 Iquum, Inc. Sample processing tubule
US7041481B2 (en) * 2003-03-14 2006-05-09 The Regents Of The University Of California Chemical amplification based on fluid partitioning
EP1649056A1 (en) * 2003-07-02 2006-04-26 Caliper Life Sciences, Inc. Methods for amplifying and detecting nucleic acids in microfluidic devices under continuous and non-continuous flow conditions.
US9597644B2 (en) 2003-09-05 2017-03-21 Stokes Bio Limited Methods for culturing and analyzing cells
US8968659B2 (en) * 2003-09-05 2015-03-03 Stokes Bio Limited Sample dispensing
EP1663497B2 (en) 2003-09-05 2020-03-25 Stokes Bio Limited A microfluidic analysis system
US8293471B2 (en) * 2004-01-28 2012-10-23 Marshall University Research Corporation Apparatus and method for a continuous rapid thermal cycle system
US7927797B2 (en) * 2004-01-28 2011-04-19 454 Life Sciences Corporation Nucleic acid amplification with continuous flow emulsion
AU2004315186B2 (en) * 2004-02-03 2008-03-13 Bioneer Corporation High throughput device for performing continuous-flow reactions
WO2005082535A1 (en) * 2004-02-27 2005-09-09 University Of Limerick Buoyancy-driven microfluidics
KR100552706B1 (en) * 2004-03-12 2006-02-20 삼성전자주식회사 Method and apparatus for nucleic acid amplification
KR100647289B1 (en) * 2004-09-15 2006-11-23 삼성전자주식회사 PCR device using Marangoni convection and method using the device
DE102004050139B4 (en) * 2004-10-14 2008-12-18 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Microfluidic processor and method of conducting a polymerase chain reaction
KR100612877B1 (en) * 2004-12-01 2006-08-14 삼성전자주식회사 Novel heating material method and device for lysing cell using the material
US8695355B2 (en) * 2004-12-08 2014-04-15 California Institute Of Technology Thermal management techniques, apparatus and methods for use in microfluidic devices
KR100601982B1 (en) 2005-01-20 2006-07-18 삼성전자주식회사 Cell lysis by heating-cooling process through endothermic reaction
US20060246493A1 (en) 2005-04-04 2006-11-02 Caliper Life Sciences, Inc. Method and apparatus for use in temperature controlled processing of microfluidic samples
US20070026439A1 (en) * 2005-07-15 2007-02-01 Applera Corporation Fluid processing device and method
EP2660482B1 (en) * 2005-08-22 2019-08-07 Life Technologies Corporation Vorrichtung, System und Verfahren unter Verwendung von nichtmischbaren Flüssigkeiten mit unterschiedlichen Volumen
WO2007047606A2 (en) * 2005-10-17 2007-04-26 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Electrokinetic thermal cycler and reactor
EP1982195A4 (en) * 2006-02-02 2010-07-07 Corbett Life Science Pty Ltd Thermocycler and sample port
US20100304446A1 (en) * 2006-02-07 2010-12-02 Stokes Bio Limited Devices, systems, and methods for amplifying nucleic acids
WO2007091230A1 (en) 2006-02-07 2007-08-16 Stokes Bio Limited A microfluidic analysis system
WO2007091228A1 (en) 2006-02-07 2007-08-16 Stokes Bio Limited A liquid bridge and system
WO2007106579A2 (en) 2006-03-15 2007-09-20 Micronics, Inc. Integrated nucleic acid assays
US10741034B2 (en) 2006-05-19 2020-08-11 Apdn (B.V.I.) Inc. Security system and method of marking an inventory item and/or person in the vicinity
US20100297748A1 (en) * 2006-09-28 2010-11-25 Stokes Bio Limited Integrated fluidic circuits
WO2008038258A1 (en) * 2006-09-28 2008-04-03 Stokes Bio Limited Microfluidic connector
EP2082061B8 (en) 2006-10-06 2020-10-07 Applied DNA Sciences, Inc. Method for a continuous rapid thermal cycle system
DE102006053451B4 (en) * 2006-11-11 2008-11-27 Microfluidic Chipshop Gmbh Microfluidic platform for temperature control of substances and / or for reactions to be tempered
CA2691451C (en) 2007-06-21 2015-03-24 Sara H. Fan Instrument and receptacles for performing processes
WO2009049268A1 (en) 2007-10-12 2009-04-16 Rheonix, Inc. Integrated microfluidic device and methods
KR101390250B1 (en) * 2008-06-23 2014-05-02 (주)바이오니아 Thermal block and Continuous Real-time Monitoring Apparatus using it
US9492797B2 (en) 2008-09-23 2016-11-15 Bio-Rad Laboratories, Inc. System for detection of spaced droplets
US9156010B2 (en) 2008-09-23 2015-10-13 Bio-Rad Laboratories, Inc. Droplet-based assay system
WO2011120006A1 (en) 2010-03-25 2011-09-29 Auantalife, Inc. A Delaware Corporation Detection system for droplet-based assays
US10512910B2 (en) 2008-09-23 2019-12-24 Bio-Rad Laboratories, Inc. Droplet-based analysis method
US9598725B2 (en) 2010-03-02 2017-03-21 Bio-Rad Laboratories, Inc. Emulsion chemistry for encapsulated droplets
US9399215B2 (en) 2012-04-13 2016-07-26 Bio-Rad Laboratories, Inc. Sample holder with a well having a wicking promoter
US9417190B2 (en) 2008-09-23 2016-08-16 Bio-Rad Laboratories, Inc. Calibrations and controls for droplet-based assays
US8951939B2 (en) 2011-07-12 2015-02-10 Bio-Rad Laboratories, Inc. Digital assays with multiplexed detection of two or more targets in the same optical channel
US8709762B2 (en) 2010-03-02 2014-04-29 Bio-Rad Laboratories, Inc. System for hot-start amplification via a multiple emulsion
US9132394B2 (en) 2008-09-23 2015-09-15 Bio-Rad Laboratories, Inc. System for detection of spaced droplets
US8633015B2 (en) 2008-09-23 2014-01-21 Bio-Rad Laboratories, Inc. Flow-based thermocycling system with thermoelectric cooler
US8663920B2 (en) 2011-07-29 2014-03-04 Bio-Rad Laboratories, Inc. Library characterization by digital assay
US9764322B2 (en) 2008-09-23 2017-09-19 Bio-Rad Laboratories, Inc. System for generating droplets with pressure monitoring
US11130128B2 (en) 2008-09-23 2021-09-28 Bio-Rad Laboratories, Inc. Detection method for a target nucleic acid
US8697011B2 (en) * 2009-05-19 2014-04-15 Stokes Bio Limited Sampling device with immiscible fluid supply tube in counter-flow arrangement
US8741660B2 (en) * 2009-05-19 2014-06-03 Stokes Bio Limited Sampling device
JP6155418B2 (en) 2009-09-02 2017-07-05 バイオ−ラッド・ラボラトリーズ・インコーポレーテッド System for mixing fluids by combining multiple emulsions
CN102791847B (en) 2010-01-12 2015-01-21 阿赫姆生物系统公司 Three-stage thermal convection apparatus and uses thereof
EP2524027A4 (en) 2010-01-12 2017-10-25 Ahram Biosystems, Inc. Two-stage thermal convection apparatus and uses thereof
KR101851117B1 (en) 2010-01-29 2018-04-23 마이크로닉스 인코포레이티드. Sample-to-answer microfluidic cartridge
CA2767182C (en) 2010-03-25 2020-03-24 Bio-Rad Laboratories, Inc. Droplet generation for droplet-based assays
CA2767114A1 (en) 2010-03-25 2011-09-29 Bio-Rad Laboratories, Inc. Droplet transport system for detection
CA3024250C (en) * 2010-11-01 2022-01-04 Bio-Rad Laboratories, Inc. System for forming emulsions
CN103534360A (en) 2011-03-18 2014-01-22 伯乐生命医学产品有限公司 Multiplexed digital assays with combinatorial use of signals
EP3789498A1 (en) 2011-04-25 2021-03-10 Bio-rad Laboratories, Inc. Methods for nucleic acid analysis
US9951386B2 (en) 2014-06-26 2018-04-24 10X Genomics, Inc. Methods and systems for processing polynucleotides
US11591637B2 (en) 2012-08-14 2023-02-28 10X Genomics, Inc. Compositions and methods for sample processing
US10752949B2 (en) 2012-08-14 2020-08-25 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10273541B2 (en) 2012-08-14 2019-04-30 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10584381B2 (en) 2012-08-14 2020-03-10 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10221442B2 (en) 2012-08-14 2019-03-05 10X Genomics, Inc. Compositions and methods for sample processing
US9701998B2 (en) 2012-12-14 2017-07-11 10X Genomics, Inc. Methods and systems for processing polynucleotides
WO2014028537A1 (en) 2012-08-14 2014-02-20 10X Technologies, Inc. Microcapsule compositions and methods
US10323279B2 (en) 2012-08-14 2019-06-18 10X Genomics, Inc. Methods and systems for processing polynucleotides
CA2894694C (en) 2012-12-14 2023-04-25 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10533221B2 (en) 2012-12-14 2020-01-14 10X Genomics, Inc. Methods and systems for processing polynucleotides
WO2014100743A2 (en) 2012-12-21 2014-06-26 Micronics, Inc. Low elasticity films for microfluidic use
EP2935908B1 (en) 2012-12-21 2019-08-14 PerkinElmer Health Sciences, Inc. Fluidic circuits and related manufacturing methods
WO2014100725A1 (en) 2012-12-21 2014-06-26 Micronics, Inc. Portable fluorescence detection system and microassay cartridge
EP3862435A1 (en) 2013-02-08 2021-08-11 10X Genomics, Inc. Polynucleotide barcode generation
US20140255270A1 (en) * 2013-02-28 2014-09-11 California Institute Of Technology Removing sacrificial layer to form liquid containment structure and methods of use thereof
US9963740B2 (en) 2013-03-07 2018-05-08 APDN (B.V.I.), Inc. Method and device for marking articles
WO2014182844A1 (en) 2013-05-07 2014-11-13 Micronics, Inc. Microfluidic devices and methods for performing serum separation and blood cross-matching
CA2911303C (en) 2013-05-07 2021-02-16 Micronics, Inc. Methods for preparation of nucleic acid-containing samples using clay minerals and alkaline solutions
WO2014182847A1 (en) 2013-05-07 2014-11-13 Micronics, Inc. Device for preparation and analysis of nucleic acids
CA2926436A1 (en) 2013-10-07 2015-04-16 Judith Murrah Multimode image and spectral reader
US9824068B2 (en) 2013-12-16 2017-11-21 10X Genomics, Inc. Methods and apparatus for sorting data
WO2015138343A1 (en) 2014-03-10 2015-09-17 Click Diagnostics, Inc. Cartridge-based thermocycler
JP2017512692A (en) 2014-03-18 2017-05-25 エーピーディーエヌ（ビー・ヴイ・アイ）・インコーポレイテッド Encrypted optical marker for security applications
US10745825B2 (en) 2014-03-18 2020-08-18 Apdn (B.V.I.) Inc. Encrypted optical markers for security applications
AU2015243445B2 (en) 2014-04-10 2020-05-28 10X Genomics, Inc. Fluidic devices, systems, and methods for encapsulating and partitioning reagents, and applications of same
CN106795553B (en) 2014-06-26 2021-06-04 10X基因组学有限公司 Methods of analyzing nucleic acids from individual cells or cell populations
CA2964472A1 (en) 2014-10-29 2016-05-06 10X Genomics, Inc. Methods and compositions for targeted nucleic acid sequencing
US9975122B2 (en) 2014-11-05 2018-05-22 10X Genomics, Inc. Instrument systems for integrated sample processing
WO2016109691A1 (en) 2014-12-31 2016-07-07 Boris Andreyev Devices and methods for molecular diagnostic testing
EP3244992B1 (en) 2015-01-12 2023-03-08 10X Genomics, Inc. Processes for barcoding nucleic acids
BR112017018054A2 (en) 2015-02-24 2018-07-24 10X Genomics Inc Methods for Covering Targeted Nucleic Acid Sequences
EP3262407B1 (en) 2015-02-24 2023-08-30 10X Genomics, Inc. Partition processing methods and systems
US11371094B2 (en) 2015-11-19 2022-06-28 10X Genomics, Inc. Systems and methods for nucleic acid processing using degenerate nucleotides
SG10202108763UA (en) 2015-12-04 2021-09-29 10X Genomics Inc Methods and compositions for nucleic acid analysis
SG11201806757XA (en) 2016-02-11 2018-09-27 10X Genomics Inc Systems, methods, and media for de novo assembly of whole genome sequence data
US10519605B2 (en) 2016-04-11 2019-12-31 APDN (B.V.I.), Inc. Method of marking cellulosic products
WO2017185067A1 (en) 2016-04-22 2017-10-26 Click Diagnostics, Inc. Printed circuit board heater for an amplification module
WO2017197040A1 (en) 2016-05-11 2017-11-16 Click Diagnostics, Inc. Devices and methods for nucleic acid extraction
WO2017197338A1 (en) 2016-05-13 2017-11-16 10X Genomics, Inc. Microfluidic systems and methods of use
MX2018015889A (en) 2016-06-29 2019-05-27 Click Diagnostics Inc Devices and methods for the detection of molecules using a flow cell.
US10995371B2 (en) 2016-10-13 2021-05-04 Apdn (B.V.I.) Inc. Composition and method of DNA marking elastomeric material
US10550429B2 (en) 2016-12-22 2020-02-04 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10011872B1 (en) 2016-12-22 2018-07-03 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10815525B2 (en) 2016-12-22 2020-10-27 10X Genomics, Inc. Methods and systems for processing polynucleotides
WO2018140966A1 (en) 2017-01-30 2018-08-02 10X Genomics, Inc. Methods and systems for droplet-based single cell barcoding
US10995333B2 (en) 2017-02-06 2021-05-04 10X Genomics, Inc. Systems and methods for nucleic acid preparation
US10920274B2 (en) 2017-02-21 2021-02-16 Apdn (B.V.I.) Inc. Nucleic acid coated submicron particles for authentication
US10844372B2 (en) 2017-05-26 2020-11-24 10X Genomics, Inc. Single cell analysis of transposase accessible chromatin
SG11201901822QA (en) 2017-05-26 2019-03-28 10X Genomics Inc Single cell analysis of transposase accessible chromatin
US10837047B2 (en) 2017-10-04 2020-11-17 10X Genomics, Inc. Compositions, methods, and systems for bead formation using improved polymers
WO2019084043A1 (en) 2017-10-26 2019-05-02 10X Genomics, Inc. Methods and systems for nuclecic acid preparation and chromatin analysis
EP3700672B1 (en) 2017-10-27 2022-12-28 10X Genomics, Inc. Methods for sample preparation and analysis
WO2019094784A1 (en) 2017-11-09 2019-05-16 Click Diagnostics, Inc. Portable molecular diagnostic device and methods for the detection of target viruses
SG11201913654QA (en) 2017-11-15 2020-01-30 10X Genomics Inc Functionalized gel beads
US10829815B2 (en) 2017-11-17 2020-11-10 10X Genomics, Inc. Methods and systems for associating physical and genetic properties of biological particles
WO2019108851A1 (en) 2017-11-30 2019-06-06 10X Genomics, Inc. Systems and methods for nucleic acid preparation and analysis
WO2019157529A1 (en) 2018-02-12 2019-08-15 10X Genomics, Inc. Methods characterizing multiple analytes from individual cells or cell populations
US11639928B2 (en) 2018-02-22 2023-05-02 10X Genomics, Inc. Methods and systems for characterizing analytes from individual cells or cell populations
SG11202009889VA (en) 2018-04-06 2020-11-27 10X Genomics Inc Systems and methods for quality control in single cell processing
US11932899B2 (en) 2018-06-07 2024-03-19 10X Genomics, Inc. Methods and systems for characterizing nucleic acid molecules
US11703427B2 (en) 2018-06-25 2023-07-18 10X Genomics, Inc. Methods and systems for cell and bead processing
US20200032335A1 (en) 2018-07-27 2020-01-30 10X Genomics, Inc. Systems and methods for metabolome analysis
US11459607B1 (en) 2018-12-10 2022-10-04 10X Genomics, Inc. Systems and methods for processing-nucleic acid molecules from a single cell using sequential co-partitioning and composite barcodes
US11845983B1 (en) 2019-01-09 2023-12-19 10X Genomics, Inc. Methods and systems for multiplexing of droplet based assays
SG11202108788TA (en) 2019-02-12 2021-09-29 10X Genomics Inc Methods for processing nucleic acid molecules
US11467153B2 (en) 2019-02-12 2022-10-11 10X Genomics, Inc. Methods for processing nucleic acid molecules
US11851683B1 (en) 2019-02-12 2023-12-26 10X Genomics, Inc. Methods and systems for selective analysis of cellular samples
US11655499B1 (en) 2019-02-25 2023-05-23 10X Genomics, Inc. Detection of sequence elements in nucleic acid molecules
WO2020185791A1 (en) 2019-03-11 2020-09-17 10X Genomics, Inc. Systems and methods for processing optically tagged beads
US11851700B1 (en) 2020-05-13 2023-12-26 10X Genomics, Inc. Methods, kits, and compositions for processing extracellular molecules
AU2022227563A1 (en) 2021-02-23 2023-08-24 10X Genomics, Inc. Probe-based analysis of nucleic acids and proteins
US20230018570A1 (en) * 2021-07-14 2023-01-19 Lawrence Livermore National Security, Llc Chemical amplification based on fluid partitioning

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6918087A (en) * 1986-02-25 1987-08-27 Applera Corporation Apparatus and method for performing automated amplification of nucleic acid sequences and assays using heating and cooling steps
AU4744890A (en) * 1988-11-10 1990-05-28 Grant Instruments (Cambridge) Limited Temperature control apparatus and uses thereof
AU6014890A (en) * 1989-08-05 1991-02-07 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Apparatus for repeated automatic execution of a thermal cycle for treatment of samples
AU6895891A (en) * 1989-11-21 1991-06-13 Kindconi Pty Limited Improved dna polymerisation device

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8105524A (en) * 1981-12-08 1983-07-01 Stork Amsterdam METHOD AND INSTALLATION FOR APPLYING AN ADJUSTABLE HEAT EXCHANGE IN A REGENERATIVE HEAT EXCHANGER.
GB2131673B (en) * 1982-12-08 1986-06-25 Apv Int Ltd High-temperature treatment of liquids
NL8300061A (en) * 1983-01-07 1984-08-01 Stork Amsterdam APPARATUS FOR HEAT TREATING A LIQUID PRODUCT, AND A METHOD FOR OPERATING AND CLEANING SUCH AN APPARATUS.
JPS60241884A (en) * 1984-05-15 1985-11-30 Tokyo Daigaku Automation cycling reaction apparatus and automatic analyzer using same
US5038852A (en) * 1986-02-25 1991-08-13 Cetus Corporation Apparatus and method for performing automated amplification of nucleic acid sequences and assays using heating and cooling steps
NL8802714A (en) * 1987-11-24 1989-06-16 Stork Amsterdam METHOD FOR THE CONTINUOUS FLOW THERMAL TREATMENT OF A PRODUCT MIX consisting of a LIQUID WITH SOLID PARTS INCLUDED THEREIN.
US4865986A (en) * 1988-10-06 1989-09-12 Coy Corporation Temperature control apparatus
WO1991007504A1 (en) * 1989-11-21 1991-05-30 Kindconi Pty. Ltd. Improved dna polymerisation device
US6242019B1 (en) * 1997-08-14 2001-06-05 Warner-Lambert Company Taste modified hard confectionery compositions containing functional ingredients

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6918087A (en) * 1986-02-25 1987-08-27 Applera Corporation Apparatus and method for performing automated amplification of nucleic acid sequences and assays using heating and cooling steps
AU4744890A (en) * 1988-11-10 1990-05-28 Grant Instruments (Cambridge) Limited Temperature control apparatus and uses thereof
AU6014890A (en) * 1989-08-05 1991-02-07 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Apparatus for repeated automatic execution of a thermal cycle for treatment of samples
AU6895891A (en) * 1989-11-21 1991-06-13 Kindconi Pty Limited Improved dna polymerisation device

Cited By (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994010564A1 (en) * 1992-11-05 1994-05-11 Evotec Biosystems Gmbh Process for separating substances from dilute solutions and suspensions
US6033880A (en) * 1993-07-28 2000-03-07 The Perkin-Elmer Corporation Nucleic acid amplification reaction apparatus and method
EP0636413A3 (en) * 1993-07-28 1995-03-29 Perkin Elmer Corp Nucleic acid amplification reaction apparatus and method.
US5720923A (en) * 1993-07-28 1998-02-24 The Perkin-Elmer Corporation Nucleic acid amplification reaction apparatus
US5779977A (en) * 1993-07-28 1998-07-14 The Perkin-Elmer Corporation Nucleic acid amplification reaction apparatus and method
EP0636413A2 (en) * 1993-07-28 1995-02-01 The Perkin-Elmer Corporation Nucleic acid amplification reaction apparatus and method
WO1996010456A1 (en) * 1994-09-30 1996-04-11 Biometra Biomedizinische Analytik Gmbh Miniaturized flow thermocycler
US5716842A (en) * 1994-09-30 1998-02-10 Biometra Biomedizinische Analytik Gmbh Miniaturized flow thermocycler
EP1022059A2 (en) * 1994-09-30 2000-07-26 Biometra Biomedizinische Analytik Gmbh Miniaturised flow thermocycler
EP1022059A3 (en) * 1994-09-30 2000-12-27 Biometra Biomedizinische Analytik Gmbh Miniaturised flow thermocycler
GB2325464A (en) * 1997-04-23 1998-11-25 Bruker Franzen Analytik Gmbh Capillary polymerase chain reaction
GB2325464B (en) * 1997-04-23 2001-09-26 Bruker Franzen Analytik Gmbh Methods and devices for fast oligonucleotide replication by polymerase chain reactions(PCR)
US6180372B1 (en) 1997-04-23 2001-01-30 Bruker Daltonik Gmbh Method and devices for extremely fast DNA replication by polymerase chain reactions (PCR)
US6428987B2 (en) 1997-04-23 2002-08-06 Bruker Daltonik Gmbh Devices for fast DNA replication by polymerase chain reactions (PCR)
WO1999041015A1 (en) * 1998-02-11 1999-08-19 Institut für Physikalische Hochtechnologie e.V. Miniaturized temperature-zone flow reactor
US6896855B1 (en) 1998-02-11 2005-05-24 Institut Fuer Physikalische Hochtechnologie E.V. Miniaturized temperature-zone flow reactor
AT4070U3 (en) * 1999-11-12 2001-07-25 Rosinger Anlagentechnik Gmbh & FERMENTATION REACTOR WITH TIP SAFETY REGARDING BIOLOGY
US7537927B2 (en) 2000-03-08 2009-05-26 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Reaction system for thermal cycling
AU2001237585B2 (en) * 2000-03-08 2006-04-27 The Secretary Of State For Defence Reaction system for thermal cycling
US7264961B2 (en) 2000-03-08 2007-09-04 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Reaction system for thermal cycling
GB2366793B (en) * 2000-09-13 2005-03-09 Imperial College Chemical processing system and method
GB2366793A (en) * 2000-09-13 2002-03-20 Imperial College Chemical processing system
DE10149684B4 (en) * 2001-10-09 2005-02-17 Clondiag Chip Technologies Gmbh Device for holding a substance library carrier
EP2354256A1 (en) * 2004-02-24 2011-08-10 Thermal Gradient Thermal cycling device
EP1784505A4 (en) * 2004-09-02 2012-12-19 Bioneer Corp Miniaturized apparatus for real-time monitoring
EP1784505A1 (en) * 2004-09-02 2007-05-16 Bioneer Corporation Miniaturized apparatus for real-time monitoring
JPWO2008126827A1 (en) * 2007-04-06 2010-07-22 ユニバーサル・バイオ・リサーチ株式会社 Temperature control apparatus and temperature control method
WO2008126827A1 (en) * 2007-04-06 2008-10-23 Universal Bio Research Co., Ltd. Temperature control device, and temperature control method
US8418929B2 (en) 2007-04-06 2013-04-16 Universal Bio Research Co., Ltd. Temperature controlling apparatus and temperature controlling method
WO2017121238A1 (en) * 2016-01-15 2017-07-20 北京酷搏科技有限公司 Thermal cycle reaction component and real-time detection device having same
RU2750599C1 (en) * 2017-06-06 2021-06-29 Ниппон Шит Глас Кампани, Лимитед Apparatus for conducting a reaction
US11541394B2 (en) 2017-06-06 2023-01-03 Nippon Sheet Glass Company, Limited Reaction processor

Also Published As

Publication number Publication date
US5270183A (en) 1993-12-14
AU1185092A (en) 1992-09-07
AU660652B2 (en) 1995-07-06

Similar Documents

Publication Publication Date Title
US5270183A (en) Device and method for the automated cycling of solutions between two or more temperatures
US5578458A (en) Mutation detection by competitive oligonucleotide priming
AU740708B2 (en) Improved cycle sequencing thermal profiles
US9518302B2 (en) Method for direct amplification from crude nucleic acid samples
US5914229A (en) Method for amplifying a polynucleotide
US20030228620A1 (en) Nested PCR employing degradable primers
CA2497740A1 (en) Multiplexed analysis of polymorphic loci by probe elongation-mediated detection
EP3006938B1 (en) Real time quantitative and qualitative analysis method for biosubstance
WO2005113803A1 (en) Detection of amplicon contamination during pcr exhibiting two different annealing temperatures
US5723298A (en) Cycle labeling and sequencing with thermostable polymerases
WO2016077750A1 (en) Methods to detect a silent carrier genotype
JP2004024035A (en) Method for detecting nucleic acid
US6015675A (en) Mutation detection by competitive oligonucleotide priming
EP3842549B1 (en) Simplified polynucleotide sequence detection method
US20010055772A1 (en) Pressure-controlled nucleic acid hybridization
EP1390533B1 (en) Analytical method and kit
AU2002253376A1 (en) Analytical method and kit
Farrell DNA amplification
AU2009287384A1 (en) Device for thermally regulating a rotationally symmetrical container
Atlas Detecting gene sequences using the polymerase chain reaction
Singh et al. Recent Developments in PCR Technology
AU641085B2 (en) Detection of bacteria using a nucleic acid amplification
Basha et al. Nucleic acid based methods in food borne pathogens
Labău RESIDUAL DISEASE IN CHRONIC MYELOID LEUKEMIA AFTER INDUCTION OF MOLECULAR REMISSION
Thomas Polymerase chain reaction and its various modifications In: Winter School on Vistas in Marine Biotechnology 5th to 26th October 2010

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU CA JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref country code: CA

Ref document number: 2100559

Kind code of ref document: A

Format of ref document f/p: F

NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase